Skip to Content

Cancer Research & Clinical Trials

The cancer team at Adventist HealthCare recognizes the important role that clinical trials play in the study of new, innovative treatments or strategies that may lead to prevention, earlier detection, better treatments or cures for conditions such as cancer. Our expert cancer research team includes physicians and clinical research nurses as well as research associates and assistants who are involved with more than 65 cancer studies each year.

Search or Browse Cancer Clinical Trials

Showing 1-7 of 7

Sorted By:

  • NRG-BR003

    Randomized phase III trial to study how well doxorubicin hydrochloride and cyclophosphamide followed by paclitaxel with or without carboplatin work in treating patients with triple-negative breast cancer.

  • PATRICIA/ML29366

    Study will examine the safety and efficacy of pertuzumab in combination with high-dose trastuzumab in adult participants with HER2-positive MBC with CNS metastases and disease progression in the brain following radiotherapy.


    International, multicenter, randomized, double-blinded, placebo-controlled study designed to compare the efficacy and safety of taselisib + fulvestrant with that of placebo + fulvestrant in postmenopausal women.

  • SystHERs Registry

    This multi-center, prospective observational study will evaluate the treatment patterns, and the safety in patients with HER2-positive (HER2+) metastatic breast cancer (MBC).

  • USO 14052

    Phase 2, open-label, single arm, multicenter, 2-stage study of eribulin mesylate administered biweekly at 1.4 mg/m2 intravenously for the treatment of participants with HER2-negative metastatic breast cancer previously treated with 2 to 5 chemotherapy regimens.

  • USOR 13033

    A clinical research study to learn if the study drug, alisertib, in combination with chemotherapy (paclitaxel), can shrink or slow tumor growth in women.

  • USOR 15130

    Study to determine if GTx-024 is effective and safe in the treatment of patients with advanced, androgen receptor positive triple negative breast cancer (AR+ TNBC).

Showing trials 1-7 of 7

Clincal Trials & Research Studies

Patient Stories

We’re writing new chapters in the lives of our patients, their families and our community daily. These are their stories:

Local Health News - In Your Inbox

Join over 40k of your friends & neighbors and get the latest news about community health programs and events when you sign-up for Adventist HealthCare & You Digital.

Subscribe Today!